| Name | Title | Contact Details |
|---|
Applied Cardiac Systems Inc is a Laguna Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Calhoun Vision is focused on developing vision correction technologies for post-cataract surgery patients.
All Stat Home Health provides a full range of In-Home and Private Duty Home Health Care, catering specifically to the needs of the patient and family. We supply nursing personnel to Hospitals, Nursing Centers, Doctor's Offices and for private duty
BI Nutraceuticals is a solutions-based botanical manufacturer, custom contract manufacturer, and supplier to the Dietary Supplement, Food & Beverage, Pharmaceutical, Personal Care, and Pet Care Industries. We are the leading manufacturer of whole herb powders and teas, standardized and drug ratio extracts, vitamins, minerals, amino acids, custom blends, drum-to-hopper (D-T-H) formulations, and granular ingredients. BI Nutraceuticals is committed to providing top-quality ingredients, starting even before the raw material comes through the door with our in-depth industry knowledge and distinguished vendor qualification program. The moment we receive the material it undergoes BI`s Protexx HP™ Green Steam™ sterilization, our patented high pressure, low moisture steam sterilization process, and a complete array of tests including Identilok®, our proprietary Species Genus identificaiton technology. The result is a product that meets a quality standard above all others. Quality is our competitive differentiator and the single most important ingredient we sell.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.